Essential role of NF-κB in transactivation of the human immunodeficiency virus long terminal repeat by the human cytomegalovirus IE1 protein

Journal of General Virology

Volumn 77, Issue 1, 1996, Pages 83-91

  Kim, Sunyoung ^a   Yu, Seung Shin ^a   Kim, Vie Narry ^a  

^a Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE; TUMOR NECROSIS FACTOR ALPHA; VIRUS PROTEIN; IE1 PROTEIN, CYTOMEGALOVIRUS; IMMEDIATE EARLY PROTEIN;

ARTICLE; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; HUMAN IMMUNODEFICIENCY VIRUS; LONG TERMINAL REPEAT; MUTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TATA BOX; TRANSACTIVATION; VIRUS CELL INTERACTION; CELL LINE; DOWN REGULATION; GENE DELETION; GENE EXPRESSION REGULATION; GENE VECTOR; GENETIC TRANSCRIPTION; GENETICS; HELA CELL; METABOLISM; MOLECULAR GENETICS; REGULATORY SEQUENCE;

BASE SEQUENCE; CELL LINE; DOWN-REGULATION; GENE EXPRESSION REGULATION, VIRAL; GENETIC VECTORS; HELA CELLS; HIV; HIV LONG TERMINAL REPEAT; HUMANS; IMMEDIATE-EARLY PROTEINS; MOLECULAR SEQUENCE DATA; NF-KAPPA B; REGULATORY SEQUENCES, NUCLEIC ACID; SEQUENCE DELETION; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION, GENETIC; VIRAL PROTEINS;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0029671021     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-77-1-83     Document Type: Article

References (48)

1. + lymphocytes. Journal of Virology 63, 1861-1868.
2. BARRY, P. A., PRATT-LOWE, E., PETERLIN, B. M. & LUCIW, P. A. (1990). Cytomegalovirus activates transcription directed by the long terminal repeat of human immunodeficiency virus type 1. Journal of Virology 64, 2932-2940.
3. BEG, A. A., FINCO, T. S., NANTERMET, P. V. & BALDWIN JR, A. S. (1993). Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of IκBa: a mechanism for NF-κB activation. Molecular and Cellular Biology 13, 3301-3310.
4. BELEC, L., GRAY, F., MIKOL, J., SCARAVILLI, F., MHIRI, C., SOBEL, A. & POIRIER, J. (1990). Cytomegalovirus (CMV) encephalomyeloradiculitis and human immunodeficiency virus (HIV) encephalitis: presence of HIV and CMV co-infected multinucleated giant cells. Acta Neuropathologica 81, 99-104.
5. BIEGALKE, B. J. & GEBALLE, A. P. (1991). Sequence requirements for activation of the HIV-1 LTR by human cytomegalovirus. Virology 183, 381-385.
6. CASAREALE, D., FIALA, M., CHANG, C. M., CONE, L. A. & MOCARSKI, E. S. (1989). Cytomegalovirus enhances lysis of HIV-infected T lymphoblasts. International Journal of Cancer 44, 124-130.
7. CHERRINGTON, J. M. & MOCARSKI, E. S. (1989). Human cytomegalovirus IE1 trans-activates the promoter-enhancer via an 18-base-pair repeat element. Journal of Virology 63, 1435-1441.
8. DAVIS, M. G., KENNEY, S. C., KAMINE, J., PAGANO, J. S. & HUANG, E.-S. (1987). Immediate-early gene region of human cytomegalovirus frans-activates the promoter of human immunodeficiency virus. Proceedings of the National Academy of Sciences, USA 84, 8642-8646.
9. DIGNAM, J. D., LEBOVITZ, R. M. & ROEDER, R. G. (1983) Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Research 11, 1475-1488.
10. EINHORN, L. & OST, A. (1984). Cytomegalovirus infection of human blood cells. Journal of Infectious Diseases 149, 207-214.
11. ENSOLI, B., LUSSO, P., SCHACHTER, F., JOSEPHS, S. F., RAPPAPORT, J., NEGRO, F., GALLO, R. C. & WONG-STAAL, F. (1989). Human herpesvirus-6 increases HIV-1 expression in co-infected T cells via nuclear factors binding to the HIV-1 enhancer. EMBO Journal 8, 3019-3027.
12. FIALA, M., CONE, L. A , CHANG, C. M. & MOCASKI, E S. (1986). Cytomegalovirus viremia increases with progressive immune deficiency in patients infected with HTLV-III. AIDS Research 2, 175-181.
13. FINKLE, C., TAPPER, M. A., KNOX, K. K. & CARRIGAN, D. R. (1991). Coinfection of cells with the human immunodeficiency virus and cytomegalovirus in lung tissues of patients with AIDS. Journal of Acquired Immune Deficiency Syndromes 4, 735-737.
14. GENDELMAN, H. E., PHELPS, W., FEIGENBAUM, L , OSTROVE, J M., ADACHI, A., HOWLEY, P. M., KHOURY, G., GINSBERG, H. S. & MARTIN, M. A. (1986). Transactivation of the human immunodeficiency virus long terminal repeat by DNA viruses. Proceedings of the National Academy of Sciences, USA 83, 9759-9763.
15. GHAZAL, P. J., YOUNG, E., GIULIETTI, C., DEMATTEI, C., GARCIA, J., GAYNOR, R., STENBERG, R. M. & NELSON, J. M. (1991). A discrete cis element in the human immunodeficiency virus long terminal repeat mediates synergistic trans activation by cytomegalovirus immediate-early proteins. Journal of Virology 65, 6735-6742.
16. GIMBLE, J. M., DUH, E., OSTROVE, J. M., GENDELMAN, H. E., MAX, E E. & RABSON, A. B. (1988). Activation of the human immunodeficiency virus long terminal repeat by herpes simplex virus type 1 is associated with induction of a nuclear factor that binds to the NF-κB/core enhancer sequence. Journal of Virology 62, 4104-4112.
17. GROSSCHEDL, R. & BALTIMORE, D. (1985). Cell-type specificity of immunoglobulin gene expression is regulated by at least three DNA sequence elements. Cell 41, 885-897.
18. HAGEMEIER, C., WALKER, S., CASWELL, R , KOUZARIDES, T. & SINCLAIR, J. (1992). The human immunodeficiency virus 80-kilodalton but not the 72-kilodalton immediate-early protein transactivates heterologous promoters in a TATA box-dependent mechanism and interacts directly with TFIID. Journal of Virology 66, 4452-4456.
19. HARRICH, D., GARCIA, J., WU, F., MITSUYASU, R., GONZALEZ, J. & GAYNOR. R. (1989). Role of Sp1-binding domains in in vivo transcriptional regulation of the human immunodeficiency virus type 1 long terminal repeat. Journal of Virology 63, 2585-2591.
20. HARRICH, D., GARCIA, J., MITSUYASU, R. & GAYNOR, R. (1990). Tar independent activation of the human immunodeficiency virus in phorbol ester stimulated T lymphocytes. EMBO Journal 9, 4417-4423.
21. HO, W.-Z., HAROUSE, J. M., RANDO, R. F., GÖNCZÖL, E., SRINIVASAN, A. & PLOTKIN, S. A. (1990). Reciprocal enhancement of gene expression and viral replication between human cytomegalovirus and human immunodeficiency virus type 1. Journal of General Virology 71, 97-103.
22. KIM, S., IKEUCHI, K., GROOPMAN, J. G. & BALTIMORE, D. (1990). Factors affecting cellular tropism of human immunodeficiency virus. Journal of Virology 64, 5600-5604.
23. KLIEWER, S., GARCIA, J., PEARSON, L., SOULTANAKIS, E , DASGUPTA, A. & GAYNOR, R. (1989). Multiple transcriptional regulatory domains in the human immunodeficiency virus type 1 long terminal repeat are involved in basal and E1A/E1B-induced promoter activity. Journal of Virology 63, 4616-4625.
24. LEE, A., LEE, K., KIM, S. & SUNG, Y. (1992). Transactivation of human immunodeficiency virus type 1 long terminal repeat-directed gene expression by the human foamy virus bell protein requires a specific DNA sequence. Journal of Virology 66, 3236-3240.
25. LEONARD, J., PARROTT, C., BUCKLER-WHITE, A. J., TURNER, W., ROSS, E K , MARTIN, M. A. & RABSON, A. B. (1989). The NF-κB binding sites in the human immunodeficiency virus type 1 long terminal repeat are not required for virus infectivity. Journal of Virology 63, 4919-4924.
26. + T lymphocytes by HIV-1 and HHV-6 Nature 337, 370-373.
27. MACHER, A. M., REICHERT, C. M., STRAUS, S E., LONGO, D L , PARRILLO, J., LANE, H. C., FAUCI, A. S. ROOK, A. H., MANISCHEWITZ, J. F. & QUINNAN JR, G. V. (1983). Death in AIDS patient: role of cytomegalovirus. New England Journal of Medicine 309, 1454.
28. MACIEJEWSKI, J. P., BRUENING, E. E., DONAHUE, R E., SELLERS, S. E., CARTER, C., YOUNG, N. S. & ST JEOR, S (1993). Infection of mononucleated phagocytes with human cytomegalovirus. Virology 195, 327-336.
29. MALLON, R., BORKOWSKI, J., ALBIN, R., PEPITONI, S., SCHWARTZ, J. & KIEFF, E. (1990). Epstein-Barr virus BZLF1 gene product activates the human immunodeficiency virus type 1 5′ long terminal repeat. Journal of Virology 64, 6282-6285.
30. MARKOVITZ, D. M., KENNEY, S., KAMINE, J., SMITH, M. S., DAVIS, M., HUANG, E.-S., ROSEN, C. & PAGANO, J. S. (1989). Disparate effects of two herpesvirus immediate-early gene trans-activators on the HIV-1 LTR. Virology 173, 750-754.
31. MINTON, E. J., TYSOE, C., SINCLAIR, J. H. & SISSONS, J G. P. (1994). Human cytomegalovirus infection of the monocyte/macrophage lineage in bone marrow. Journal of Virology 68, 4017-4021.
32. MOSCA, J D., BEDNARIK, D. P., RAJ, N. B. K., ROSEN, C. A., SODROSKI, J G., HASELTINE, W A., HAYWARD, G. S. & PITHA, P. M. (1987). Activation of human immunodeficiency virus by herpes virus infection: identification of a region within the long terminal repeat that responds to a transacting factor encoded by herpes simplex virus 1. Proceedings of the National Academy of Sciences, USA 84, 7408-7412
33. NABEL, G. & BALTIMORE, D (1987). An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature 326, 711-713.
34. NELSON, J. A , REYNOLDS-KOHLER, C., OLDSTONE, M. B. A. & WILEY, C. A. (1988). HIV and HCMV coinfect brain cells in patients with AIDS. Virology 165, 286-290.
35. NELSON, J. A., GHAZAL, P. & WILEY, C. A. (1990). Role of opportunistic infection in AIDS. AIDS 4, 1-10.
36. NOWLIN, D. M., COOPER, N. R. & COMPTON, T (1991) Expression of a human cytomegalovirus receptor correlates with infectibility of cells. Journal of Virology 65, 3114-3121.
37. OSTROVE, J. M., LEONARD, J., WECK, K. E., RABSON, A. B. & GENDELMAN, H. E. (1987). Activation of the human immunodeficiency virus by herpes simplex virus type 1. Journal of Virology 61, 3726-3732.
38. PERKINS, N. D., EDWARDS, N. L., DUCKETT, C. S., AGRANOFF, A. B., SCHMID, R. M. & NABEL, G. J. (1993). A cooperative interaction between NF-κB and Sp1 is required for HIV-1 enhancer activation. EMBO Journal 12, 3551-3558.
39. PIERCE, J. W., LENARDO, M. & BALTIMORE, D. (1988). Oligonucleotide that binds nuclear factor NF-κB acts as a lymphoid-specific and inducible enhancer element. Proceedings of the National Academy of Sciences, USA 85, 1482-1486
40. RANDO, R. F., PELLET, P. E., LUCIW, P. A., BOHAN, C. A. & SRINIVASAN, A. (1987). Transactivation of the human immunodeficiency virus by herpesviruses. Oncogene 1, 13-18.
41. RANDO, R. F., SRINIVASAN, A., FEINGOLD, J., GONCZOL, E. & PLOTKIN, S. (1990). Characterization of multiple molecular interactions between human cytomegalovirus (HCMV) and human immunodeficiency virus type 1 (HIV-1). Virology 176, 87-97.
42. RICE, G. P. A., SCHRIER, R. D. & OLDSTONE, M. B. A. (1984). Cytomegalovirus infects human lymphocytes and monocytes: virus expression is restricted to immediate-early gene products. Proceedings of the National Academy of Sciences, USA 81, 6134-6138.
43. SAKAGUCHI, M., ZENZIE-GREGORY, B., GROOPMAN, J. E., SMALE, S. T. & KIM, S. (1991). Alternative pathway for induction of human immunodeficiency virus gene expression: involvement of the general transcription machinery. Journal of Virology 65, 5448-5456.
44. SAMBUCETTI, L. C., CHERRINGTON, J. M., WILKINSON, G. W. & MOCARSKI, E. S. (1989). NF-κB activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation. EMBO Journal 8, 4251-4258.
45. SCHRIER, R. D., NELSON, J. A. & OLDSTONE, M. B. A. (1985). Detection of human cytomegalovirus in peripheral blood lymphocytes in a natural infection. Science 230, 1048-1051.
46. SKOLNIK, P. R., KOSLOFF, B. R. & HIRSCH, M. S. (1988). Bidirectional interactions between human immunodeficiency virus type 1 and cytomegalovirus. Journal of Infectious Diseases 157, 508-514.
47. WALKER, S., HAGEMEIER, C., SISSONS, J. G. P. & SINCLAIR, J. H. (1992). A 10-base pair element of the human immunodeficiency virus type 1 long terminal repeat (LTR) is an absolute requirement for transactivation by the human cytomegalovirus 72-kilodalton IE1 protein but can be compensated for by other LTR regions in transactivation by the 80-kilodalton IE2 protein. Journal of Virology 66, 1543-1550.
48. WEBSTER, A., LEE, C. A., COOK, D G., GRUNDY, J. E., EMERY, V. C., KERNOFF, P. B. A & GRIFFITHS, P. D. (1989). Cytomegalovirus infection and progression towards AIDS in haemophiliacs with human immunodeficiency virus infection. Lancet ii, 63-65.